Alexion Pharmaceuticals Thought Leader Liaison, US Metabolics, Central in Boston, Massachusetts
The Thought Leader Liaison, US Metabolics (TLL) role is a senior field based position within the US commercial organization that will focus on commercial KOL relationship engagement, promotional speaker development, attendance to key conferences, support the execution of promotional HCP programs, partner with the diagnostics team, and aid in the execution of non personal promotion initiatives. Time in this role will be split between LAL-D and HPP. The position will report to the Director of TLLs and be part of the US Metabolics Marketing team.
Job Duties & Responsibilities
Partner with marketing and medical to identify physician speakers to deliver approved MLR promotional slide decks
Develop physician speakers to provide high quality promotional education
Ensure appropriate and compliant execution of speaker programs (LAL-D only)
Monitor speaker performance at programs
Provide field-based training on speaker programs for when needed (focus on promotional speakers not covered by MSLs for LAL-D)
Supports on-label conversations when needed
Executes physician engagement activities in the field and key congresses
Execute non personal promotion initiatives leveraging data
Compliant Collaboration with Regional Field Team
Marketing Strategy: Works with cross-functional teams and marketing team to provide key customer insights and input on strategy, tactics, and messaging, and program execution
Diagnostic Strategy: Works with cross-functional teams and diagnostic team to provide key customer insights and input on strategy, tactics, and messaging, and program execution
Compliance & Integrity: Works with the highest degree of professionalism and in accordance with the company’s code of Ethics and Business Conduct
Bachelor’s Degree in a relevant field
7 plus years’ work experience in biotech
Experience in one or more of the following: field sales, product marketing, or thought leader engagement
Working knowledge of Thought Leader engagement practices.
Clinical, technical and scientific knowledge and aptitude in complex disease states
Demonstrated ability to execute against strategic and tactical plans under short timelines
Effective verbal and written communication skills and organizational abilities
Self-driven with strong organizing and planning skills
Highly collaborative with the ability to manage multiple projects simultaneously
Proven ability to manage large geographical territory
Valid driver’s license and clean driving
Travel requirements: Willing to travel >50% of the time including significant overnight and weekend travel
Graduate degree (MSc, MSN, MBA)
Prior experience and/or relationships within the Metabolics area
Prior experience in Marketing or thought leader engagement preferred
Some opportunities happen only once in a lifetime - like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders and cardiology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.